Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Greenberg

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Pediatric Infectious Disease Journal|August 12, 2005
Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescentsDavid P Greenberg
Clinical Pediatrics|March 28, 2003
Vaccine interchangeabilityDavid P Greenberg, Sandor Feldman
Expert Review of Vaccines|December 24, 2005
A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccineSteven Black, David P Greenberg
Pediatrics|June 4, 2002
2-dose hepatitis vaccination versus 3-dose regimenAllen S Meyerhoff, David P Greenberg
The Pediatric Infectious Disease Journal|May 7, 2005
Summary: health and economic burden of pertussisDavid P Greenberg, J Jaime Caro
Vaccine|December 3, 2014
Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniorsAyman Chit, Julie Roiz, Benjamin Briquet, et al.
Pediatric Annals|August 6, 2013
Prevention and control of influenza and dengue through vaccine developmentDavid P Greenberg, Corwin A Robertson, Daniel M Gordon
Vaccine|January 24, 2019
Persistence of bactericidal antibodies 4 years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)Corwin A Robertson, James Hedrick, Ehab Bassily, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Health burden of pertussis in infants and childrenDavid P Greenberg, Carl-Heinz Wirsing von König, Ulrich Heininger
Expert Review of Vaccines|July 27, 2016
Fluzone® Intradermal Quadrivalent Influenza VaccineCorwin A Robertson, Peter Tsang, Victoria A Landolfi, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Pediatric Infectious Disease Journal|August 12, 2005
Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescentsDavid P Greenberg
Clinical Pediatrics|March 28, 2003
Vaccine interchangeabilityDavid P Greenberg, Sandor Feldman
Expert Review of Vaccines|December 24, 2005
A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccineSteven Black, David P Greenberg
Pediatrics|June 4, 2002
2-dose hepatitis vaccination versus 3-dose regimenAllen S Meyerhoff, David P Greenberg
The Pediatric Infectious Disease Journal|May 7, 2005
Summary: health and economic burden of pertussisDavid P Greenberg, J Jaime Caro
Vaccine|December 3, 2014
Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniorsAyman Chit, Julie Roiz, Benjamin Briquet, et al.
Pediatric Annals|August 6, 2013
Prevention and control of influenza and dengue through vaccine developmentDavid P Greenberg, Corwin A Robertson, Daniel M Gordon
Vaccine|January 24, 2019
Persistence of bactericidal antibodies 4 years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)Corwin A Robertson, James Hedrick, Ehab Bassily, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Health burden of pertussis in infants and childrenDavid P Greenberg, Carl-Heinz Wirsing von König, Ulrich Heininger
Expert Review of Vaccines|July 27, 2016
Fluzone® Intradermal Quadrivalent Influenza VaccineCorwin A Robertson, Peter Tsang, Victoria A Landolfi, et al.
Pageof 7